Warner-Jenkinson Co. v. Hilton Davis Chemical Co.

This article relies excessively on references to primary sources. Please improve this article by adding secondary or tertiary sources. Find sources: "Warner-Jenkinson Co. v. Hilton Davis Chemical Co." – news · newspapers · books · scholar · JSTOR (November 2019) (Learn how and when to remove this message)

Warner-Jenkinson Company, Inc. v. Hilton Davis Chemical Co.
F.3d 1512 (Fed. Cir. 1995); cert. granted, 516 U.S. 1145 (1996).
Holding
The Doctrine of Equivalents is consistent with the 1952 revisions to the Patent Act and patentees may attempt to prove that an amendment was not made to be limiting. Reversed and remanded.
Court membership
Chief Justice William Rehnquist Associate Justices John P. Stevens · Sandra Day O'Connor Antonin Scalia · Anthony Kennedy David Souter · Clarence Thomas Ruth Bader Ginsburg · Stephen Breyer
Case opinions
Majority	Thomas, joined by unanimous
Concurrence	Ginsburg, joined by Kennedy
Laws applied
Patent Act of 1952

Warner-Jenkinson Company, Inc. v. Hilton Davis Chemical Co., 520 U.S. 17 (1997), was a United States Supreme Court decision in the area of patent law, affirming the continued vitality of the doctrine of equivalents while making some important refinements to the doctrine.^[1]

The

The plaintiff sued for infringement, conceding that the defendant's process did not literally infringe, but relying on the doctrine of equivalents to support the claim of infringement. The defendant argued that the doctrine of equivalents was no longer appropriate for courts to use because Congress had made some changes to the patent statute after the Supreme Court's 1950 decision establishing the propriety of using the doctrine.

Is the doctrine of equivalents still in force? How is the plaintiff's amendment to figure into the problem?

The Court, in an opinion by Justice Clarence Thomas, held that the doctrine of equivalents had not been eliminated by changes to the patent statute. Instead, the Court determined that the United States Congress would have explicitly stated that they were eliminating the doctrine if that was their intent. The Court enunciated a test for amendments, finding that if the plaintiff can prove the reason for the amendment was not to limit the patent, then infringement was still possible. The case was remanded to the trial court to determine if the plaintiff could explain his lower pH limit.

Justice Ruth Bader Ginsburg wrote a concurring opinion, in which Justice Anthony Kennedy joined, expressing some concern about whether patentees would have sufficient notice that they must explain the reasons for their amendments. Nevertheless, they agreed with the remand to the lower court to establish the plaintiff's reason for setting a lower limit.

• List of United States Supreme Court cases, volume 520
• List of United States Supreme Court cases
• Lists of United States Supreme Court cases by volume

• Text of Warner-Jenkinson Company, Inc. v. Hilton Davis Chemical Co., 520 U.S. 17 (1997) is available from: Cornell CourtListener Google Scholar Justia Library of Congress Oyez (oral argument audio)